Catastrophic expenditure on medicines in brazil

dc.contributor.authorLuiza, Vera Lucia
dc.contributor.authorLeao Tavares, Noemia Urruth
dc.contributor.authorOliveira, Maria Auxiliadora
dc.contributor.authorDourado Arrais, Paulo Sergio
dc.contributor.authorRamos, Luiz Roberto [UNIFESP]
dc.contributor.authorDal Pizzol, Tatiane da Silva
dc.contributor.authorMengue, Sotero Serrate
dc.contributor.authorFarias, Mareni Rocha
dc.contributor.authorBertoldi, Andrea Damaso
dc.date.accessioned2019-01-21T10:29:36Z
dc.date.available2019-01-21T10:29:36Z
dc.date.issued2016
dc.description.abstractOBJECTIVE: To describe the magnitude of the expenditure on medicines in Brazil according to region, household size and composition in terms of residents in a situation of dependency. METHODS: Population-based data from the national household survey were used, with probabilistic sample, applied between September 2013 and February 2014 in urban households. The expenditure on medicines was the main outcome of interest. The prevalence and confidence intervals (95% CI) of the outcomes were stratified according to socioeconomic classification and calculated according to the region, the number of residents dependent on income, the presence of children under five years and residents in a situation of dependency by age. RESULTS: In about one of every 17 households (5.3%) catastrophic health expenditure was reported and, in 3.2%, the medicines were reported as one of the items responsible for this situation. The presence of three or more residents (3.6%) and resident in a situation of dependency (3.6%) were the ones that most reported expenditure on medicines. Southeast was the region with the lowest prevalence of expenditure on medicines. The prevalence of households with catastrophic health expenditure and on medicines in relation to the total of households showed a regressive tendency for economic classes. CONCLUSIONS: Catastrophic health expenditure was present in 5.3%, and catastrophic expenditure on medicines in 3.2% of the households. Multi-person households, presence of residents in a situation of economic dependency and belonging to the class D or E had the highest proportion of catastrophic expenditure on medicines. Although the problem is important, permeated by aspects of iniquity, Brazilian policies seem to be protecting families from catastrophic expenditure on health and on medicine.en
dc.description.affiliationDepartamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliationDepartamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliationDepartamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliationDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliationDepartamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationPrograma de Pós-Graduação em Epidemiologia. Faculdade de Medicina. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationDepartamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliationDepartamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationUnifespDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sourceWeb of Science
dc.description.sponsorshipDepartment for Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs of the Brazilian Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.description.sponsorshipDepartment of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs of the Brazilian Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.description.sponsorshipIDSCTIE/MS: 25000.111834/2
dc.format.extent15s
dc.identifierhttp://dx.doi.org/10.1590/s1518-8787.2016050006172
dc.identifier.citationRevista De Saude Publica. Sao paulo, v. 50, n. 2, p. 15s, 2016.
dc.identifier.doi10.1590/S1518-8787.2016050006172
dc.identifier.fileS0034-89102016000300302.pdf
dc.identifier.issn0034-8910
dc.identifier.scieloS0034-89102016000300302
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/49284
dc.identifier.wosWOS:000391447400012
dc.language.isoeng
dc.publisherElsevier Science Bv
dc.relation.ispartofRevista De Saude Publica
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHealth Expenditureen
dc.subjectAccessen
dc.subjectCountriesen
dc.subjectSystemen
dc.subjectCareen
dc.titleCatastrophic expenditure on medicines in brazilen
dc.titleGasto catastrófico com medicamentos no Brasilpt
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções